SEARCH OUR PAGES

About OSE
Immunotherapeutics

About OSE
Immunotherapeutics

OSE Immunotherapeutics is a clinical-stage biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmmune diseases.

Company Profile

OSE Immunotherapeutics is a clinical-stage biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmmune diseases.

The company utilizes several scientific and technological approaches including neoepitopes and agonist/antagonist monoclonal antibodies, all ideally positioned to fight cancer and autoimmune diseases. Our first-in-class pipeline offers a diversified risk profile, ranging from registrational to clinical stage to R&D.

These new generation products are optimized to better target key receptors of the immune response’s activation or regulation, thus allowing for longer therapeutic effects.

Passionate

about making a difference in the fields of immuno-oncology and autoimmune diseases through acting on immunological pathways.

Dedicated

to leveraging our existing research platform and assets to deliver first-in-class candidates in clinical development.

Partnerships

focused to ensure, through premier international pharma, clinical and academic collaborations, the fastest possible delivery of our product candidates to patients in need.

The company relies upon its international and complementary team of experts involved in the research and optimisation of drug candidates, pharmaceutical development and drug registration to develop the next wave of novel immunotherapies. Based in Nantes (Head Office) and Paris, OSE Immunotherapeutics has more than 30 employees and is listed on Euronext Paris.

Governance

  • Dominique COSTANTINI, MD, Immunology

    Chairman and Director of Early Development

    +
  • Maryvonne HIANCE

    Vice Chairman & Director of Strategy

    +
  • Alexis PEYROLES

    Director, Chief Executive Officer

    +
  • Sophie BROUARD

    Director

    +
  • Jean-Patrick DEMONSANG

    Director

    +
  • Brigitte DRENO, MD

    Director

    +
  • Walter FLAMENBAUM, MD

    Director

    +
  • Didier HOCH, MD

    Director

    +
  • Gérard TOBELEM, MD

    Director

    +
Charger plus
  • Alexis PEYROLES

    Chief Executive Officer

    +
  • Dominique COSTANTINI, MD

    Chairman & Director of Early Development

    +
  • Maryvonne HIANCE

    Vice Chairman & Director of Strategy

    +
  • Bernard VANHOVE, PhD

    Chief Operating Officer, Director of R&D and International Scientific Collaborations

    +
  • Frédérique CORALLO, MD

    Chief Medical Officer, Autoimmune Diseases

    +
  • Bérangère VASSEUR, MD

    Chief Medical Officer, Immuno-Oncology

    +
  • Nicolas POIRIER, PhD

    Chief Scientific Officer

    +
  • Emilienne SOMA, PharmD, PhD

    Director of Pharma Program Development

    +
  • Jean-Pascal CONDUZORGUES, PharmD

    Qualified Person (QP)

    +
  • Anne-Laure AUTRET-CORNET

    Chief Financial Officer

    +
Charger plus

Careers

OSE Immunotherapeutics offers the opportunity to join a stimulating and collaborative environment which is part of an international network of academic and industrial partners. When recruiting, we are looking for highly creative people with expertise to join an entrepreneurial team committed to developing breakthrough treatments for patients who need innovative therapeutic options.
If you are interested to join the team, please send your resume to recrutement@ose-immuno.com